Opportunity
Simpler Grants.gov #FOR-AR-26-002
NIAMS Small Grant Program (R03) for Career Development Awardees – Clinical Trials Not Allowed
Buyer
National Institutes of Health
Posted
May 05, 2025
Respond By
October 20, 2025
Identifier
FOR-AR-26-002
NAICS
541715
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), is preparing to release a Notice of Funding Opportunity (NOFO) for a Small Grant (R03) program: - Targeted at recipients of NIAMS-supported K01, K08, K23, and K25 career development awards, as well as similar awardees from organizations in NIAMS mission areas - Supports research projects including: - Pilot and feasibility studies - Secondary analysis of existing data - Small, self-contained research projects - Development of research methodology - Development of new research technology - Clinical trials of any phase are explicitly excluded - Designed to help scientists transition to independent investigator status and supplement their career development awards - Eligible applicants include: - Independent school districts - Higher education institutions - State and county governments - Public and Indian housing authorities - Federally recognized Native American tribal governments - Nonprofits and businesses - No specific OEMs, vendors, or product/service procurements are involved, as this is a research grant opportunity - Place of performance and contracting office: National Institutes of Health (NIH)
Description
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) plans to publish a Notice of Funding Opportunity (NOFO) for a Small Grant (R03) program targeting NIAMS-supported K01, K08, K23, and K25 recipients and career development awardees in NIAMS mission areas. This limited competition aims to support research projects such as pilot studies, secondary data analysis, and development of research methodology or technology, excluding clinical trials. The program is designed to help scientists transition to independent investigator status by providing additional support for subsequent R01 or equivalent applications. Eligible applicants include various educational institutions, government entities, nonprofits, and businesses. Applications are not currently being solicited but will open with an estimated post date of August 20, 2025, and a due date of October 20, 2025.